Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways

Area of Science:

• Oral microbiology
• Immunology
• Cell biology

Background:

• Prostaglandin E2 (PGE2) is crucial in bone resorption during inflammatory conditions like periodontitis.
• PGE2 exerts its effects through EP1-EP4 receptors.
• The role of Prevotella intermedia in regulating PGE2 and EP expression in periodontal tissues is not fully understood.

Purpose of the Study:

• To investigate if Prevotella intermedia influences PGE2 production and EP receptor expression in human periodontal ligament fibroblasts (hPDLs).
• To explore the signaling pathways mediating PGE2 production induced by P. intermedia.

Main Methods:

• hPDLs were treated with P. intermedia.
• PGE2 production and cyclooxygenase-2 (COX-2) expression were measured.
• Specific inhibitors for various signaling pathways (ERK, JNK, p38, PI3K, PKC, cAMP, PKA) were used.
• EP1 receptor expression was analyzed.

Main Results:

• P. intermedia dose- and time-dependently increased PGE2 production and COX-2 expression in hPDLs.
• COX-2 inhibitors (Indomethacin, NS-398) blocked PGE2 production but not COX-2 expression.
• Signaling pathways including ERK, JNK, p38, PI3K, and PKC were involved in P. intermedia-induced COX-2 and PGE2 expression.
• P. intermedia reduced EP1 expression in a concentration- and time-dependent manner.

Conclusions:

• P. intermedia induces PGE2 production in hPDLs through a COX-2-dependent mechanism.
• Multiple signaling pathways mediate this induction.
• P. intermedia also downregulates EP1 receptor expression in hPDLs.